RECRUITING
Study of Subcutaneously Administered ENT-03 for the Treatment of Obesity and Diabetes
Single center, single-dose, randomized, placebo-controlled, dose-escalating study to evaluate, safety, tolerability, pharmacokinetics, and pharmacodyn...
Conditions:
Obesity
Diabetes Mellitus, Type 2
Locations:
📍
San Diego, California, United States